Open a free Demat account & get ₹500 in stocks.Claim
Nifty 5022,780.251.56%H 23,080.25 · L 22,762.2as of 3:31 PM IST|Sensex72,771.721.52%H 73,740.85 · L 72,716.23as of 3:32 PM IST|Bank Nifty54,471.651.99%H 55,390.1 · L 54,437.7as of 3:31 PM IST|USD / INR₹95.980.19%H ₹95.99 · L ₹95.8as of 3:45 PM IST|Gold Intl (10g)₹1,29,222.063.09%H ₹1,33,171.92 · L ₹1,28,762.28as of 3:53 PM IST|Silver Intl (1kg)₹1,90,364.634.8%H ₹1,99,529.53 · L ₹1,89,192.01as of 3:53 PM IST|Crude WTI₹9,234.244.11%H ₹9,256.31 · L ₹8,895.43as of 3:53 PM IST|Bitcoin₹79,49,7322.28%H ₹80,40,254.86 · L ₹78,59,209.14as of 4:01 PM IST|Ethereum₹2,54,3222.12%H ₹2,57,016.54 · L ₹2,51,627.46as of 4:01 PM IST|Nifty 5022,780.251.56%H 23,080.25 · L 22,762.2as of 3:31 PM IST|Sensex72,771.721.52%H 73,740.85 · L 72,716.23as of 3:32 PM IST|Bank Nifty54,471.651.99%H 55,390.1 · L 54,437.7as of 3:31 PM IST|USD / INR₹95.980.19%H ₹95.99 · L ₹95.8as of 3:45 PM IST|Gold Intl (10g)₹1,29,222.063.09%H ₹1,33,171.92 · L ₹1,28,762.28as of 3:53 PM IST|Silver Intl (1kg)₹1,90,364.634.8%H ₹1,99,529.53 · L ₹1,89,192.01as of 3:53 PM IST|Crude WTI₹9,234.244.11%H ₹9,256.31 · L ₹8,895.43as of 3:53 PM IST|Bitcoin₹79,49,7322.28%H ₹80,40,254.86 · L ₹78,59,209.14as of 4:01 PM IST|Ethereum₹2,54,3222.12%H ₹2,57,016.54 · L ₹2,51,627.46as of 4:01 PM IST|
Topicin IPOs

Debt Repayment

Latest news, explainers and analysis on Debt Repayment. Tracking 4 stories on Arth Vani.

4 stories tracked

Connected in the graph

Latest on Debt Repayment

Symbiotec Pharmalab Plans ₹150 Crore IPO for Debt Repayment, Expansion
IPOBreaking
IPOs

Symbiotec Pharmalab Plans ₹150 Crore IPO for Debt Repayment, Expansion

Symbiotec Pharmalab, a global leader in corticosteroid and steroidal-hormone APIs, is planning an Initial Public Offering (IPO) to raise ₹150 crore. The funds are earmarked for repaying existing debt and expanding its operational capabilities. The company has shown consistent revenue and EBITDA growth, primarily driven by its international market presence, particularly in Europe.

35d ago·1 min readListen
Zetwerk Files Updated IPO Papers: Plans to Raise Funds to Repay ₹1,800 Crore Debt
IPOBreaking
IPOs

Zetwerk Files Updated IPO Papers: Plans to Raise Funds to Repay ₹1,800 Crore Debt

Manufacturing unicorn Zetwerk has filed updated draft papers with SEBI for its upcoming Initial Public Offering. The company intends to utilize ₹1,250 crore from the fresh issue to clear its own debt and another ₹550 crore to settle subsidiary borrowings.

45d ago·1 min readListen
Manipal Health Eyes ₹8,000 Cr IPO for Expansion, Debt Repayment
IPOBreaking
IPOs

Manipal Health Eyes ₹8,000 Cr IPO for Expansion, Debt Repayment

Manipal Health Enterprises is planning an ₹8,000 crore Initial Public Offering (IPO) to fund its expansion and repay debt. While the company has shown strong revenue growth, investors are advised to watch for post-listing performance due to aggressive pricing concerns.

60d ago·1 min readListen
PC Jeweller Repays Consortium Bank Debt, Eyes Debt-Free Status by Q2 FY27
Stock Market

PC Jeweller Repays Consortium Bank Debt, Eyes Debt-Free Status by Q2 FY27

PC Jeweller's shares saw a significant jump after the company announced it has cleared outstanding dues to two of its 14 consortium banks. This move is a crucial step in the company's turnaround strategy, with plans to become debt-free by the second quarter of FY27.

82d ago·1 min readListen
IPOs products
Compare & act on the right product for this topic
Smart picks
Nippon India Small Cap Fund
Nippon India Mutual Fund · Small Cap
15.6%
3Y CAGR
Bharat Mobility IPO
Mainboard · Auto
+20.5%
GMP
View IPO
Parag Parikh Flexi Cap Fund
PPFAS Mutual Fund · Flexi Cap
12.9%
3Y CAGR
GreenVolt Energy IPO
Mainboard · Renewables
+13.8%
GMP
View IPO
Mirae Asset ELSS Tax Saver Fund
Mirae Asset Mutual Fund · ELSS
11.9%
3Y CAGR
ICICI Prudential Balanced Advantage Fund
ICICI Prudential Mutual Fund · Hybrid
11.0%
3Y CAGR

IPO investments are subject to market risk and allotment. Read the RHP / prospectus before applying; grey-market premium (GMP) is unofficial and unreliable. Some listings may be sponsored. Not investment advice.

Explore all entities in the Knowledge Graph